These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15229776)

  • 1. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
    Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
    Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohort.
    Risse JH; Rabe C; Pauleit D; Reichmann K; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Nuklearmedizin; 2006; 45(4):185-92. PubMed ID: 16964345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
    Raoul JL; Boucher E; Roland V; Garin E
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
    Novell JR; Hilson AJ
    J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
    [No Abstract]   [Full Text] [Related]  

  • 7. Iodine-131-lipiodol therapy in hepatic tumours.
    Ahmadzadehfar H; Sabet A; Wilhelm K; Biersack HJ; Risse J
    Methods; 2011 Nov; 55(3):246-52. PubMed ID: 21664971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.
    Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of unresectable hepatocellular carcinoma with transarterial radioembolization: iodine-131-lipiodol.
    Lau WY; Lai EC
    ANZ J Surg; 2008 May; 78(5):331-2. PubMed ID: 18380721
    [No Abstract]   [Full Text] [Related]  

  • 10. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
    Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
    Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma.
    Brans B; Van Laere K; Gemmel F; Defreyne L; Vanlangenhove P; Troisi R; Van Vlierberghe H; Colle I; De Hemptinne B; Dierckx RA
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):928-32. PubMed ID: 12111134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases].
    Derhy S; Bessis L; Atallah R; Ajavon Y; Eisele G; Roche A
    Gastroenterol Clin Biol; 1990; 14(11):893-5. PubMed ID: 2177429
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibility of radiotherapy of hepatic cancer by transcatheter arterial embolization with radioactive Lipiodol].
    Kobayashi H; Nakajo M; Shimabukuro K; Shirono K; Sakata H; Oyama T; Sonoda T; Shinohara S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jan; 44(1):96-8. PubMed ID: 6330667
    [No Abstract]   [Full Text] [Related]  

  • 15. [Targeting cancer chemotherapy used Lipiodol as a carrier].
    Konno T
    Nihon Rinsho; 1989 Jun; 47(6):1384-90. PubMed ID: 2549286
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual atrophic change after repeated arterial therapy for hepatocellular carcinoma: report of a case.
    Komori T; Sasaki Y; Yamada T; Ohigashi H; Ishikawa O; Inoue E; Ishiguro S; Seki T; Imaoka S
    Surg Today; 2004; 34(1):76-9. PubMed ID: 14714235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
    Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
    J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarterial HCC therapy with I-131-Lipiodol.
    Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
    Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.